Get the Stockscreener App
9.61
0.10%
-0.010
After Hours:
9.79
0.18
+1.87%
Niagen Bioscience Inc stock is traded at $9.61, with a volume of 851.31K.
It is down -0.10% in the last 24 hours and down -6.34% over the past month.
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.
See More
Previous Close:
$9.62
Open:
$9.53
24h Volume:
851.31K
Relative Volume:
0.80
Market Cap:
$766.43M
Revenue:
$116.30M
Net Income/Loss:
$17.73M
P/E Ratio:
45.76
EPS:
0.21
Net Cash Flow:
$20.88M
1W Performance:
+2.13%
1M Performance:
-6.34%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$9.49
$9.92
1-Week Range:
$9.16
$9.92
52-Week Range:
$5.33
$14.69
Niagen Bioscience Inc Stock (NAGE) Company Profile
Name
Niagen Bioscience Inc
Sector
Industry
Phone
310-388-6706
Address
10900 WILSHIRE BLVD, LOS ANGELES
Compare NAGE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NAGE
Niagen Bioscience Inc
|
9.61 | 765.63M | 116.30M | 17.73M | 20.88M | 0.21 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Niagen Bioscience Inc Stock (NAGE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-27-25 | Initiated | Canaccord Genuity | Buy |
| Aug-16-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Aug-11-22 | Downgrade | B. Riley Securities | Buy → Neutral |
| Mar-08-22 | Initiated | ROTH Capital | Buy |
| Oct-16-19 | Initiated | Oppenheimer | Outperform |
| Feb-14-19 | Initiated | B. Riley FBR | Buy |
| Nov-27-17 | Resumed | H.C. Wainwright | Buy |
| Sep-25-17 | Initiated | Ladenburg Thalmann | Buy |
| Jan-03-17 | Initiated | Rodman & Renshaw | Buy |
View All
Niagen Bioscience Inc Stock (NAGE) Latest News
Niagen Bioscience (NASDAQ:NAGE) Cut to Buy at Wall Street Zen - MarketBeat
Risk vs reward if holding onto Niagen Bioscience Inc.July 2025 Review & High Conviction Investment Ideas - Newser
What momentum shifts mean for Niagen Bioscience Inc.Quarterly Profit Review & Technical Pattern Recognition Alerts - Newser
Will Niagen Bioscience Inc. outperform the marketJuly 2025 Drop Watch & Free Weekly Watchlist of Top Performers - Newser
Exit strategy if you’re trapped in Niagen Bioscience Inc.July 2025 Market Mood & Real-Time Chart Pattern Alerts - Newser
Will Niagen Bioscience Inc. continue its uptrendPortfolio Risk Summary & Low Drawdown Trading Techniques - Newser
Visual trend scoring systems applied to Niagen Bioscience Inc.2025 Geopolitical Influence & Reliable Breakout Stock Forecasts - Newser
Will Niagen Bioscience Inc. bounce back from current supportWeekly Profit Analysis & Fast Entry and Exit Trade Plans - Newser
Niagen Bioscience Inc.’s volatility index tracking explainedGold Moves & Free AI Powered Buy and Sell Recommendations - Newser
Key metrics from Niagen Bioscience Inc.’s quarterly data2025 Market Overview & Risk Managed Trade Strategies - Newser
Volume spikes in Niagen Bioscience Inc. stock – what they mean2025 Price Momentum & Fast Momentum Entry Tips - Newser
Is Niagen Bioscience Inc. forming a reversal patternJuly 2025 Pullbacks & AI Forecasted Entry and Exit Points - Newser
Applying Elliott Wave Theory to Niagen Bioscience Inc.Oil Prices & High Yield Stock Recommendations - Newser
Using economic indicators to assess Niagen Bioscience Inc. potentialRate Cut & Technical Pattern Recognition Alerts - Newser
Analyzing drawdowns of Niagen Bioscience Inc. with statistical toolsPortfolio Value Report & Stepwise Swing Trade Plans - Newser
Is a relief rally coming for Niagen Bioscience Inc. holdersWeekly Profit Report & Daily Chart Pattern Signals - Newser
Analyzing Niagen Bioscience Inc. with multi timeframe chartsWeekly Market Outlook & Daily Profit Focused Screening - Newser
Applying big data sentiment scoring on Niagen Bioscience Inc.Portfolio Value Report & Risk Controlled Swing Alerts - Newser
Is Niagen Bioscience Inc. stock poised for growth2025 Geopolitical Influence & Verified Momentum Stock Alerts - Newser
Is Niagen Bioscience Inc. still worth holding after the dip2025 Major Catalysts & Real-Time Volume Spike Alerts - Newser
Is it too late to sell Niagen Bioscience Inc.Market Volume Report & Free High Accuracy Swing Entry Alerts - Newser
Detecting support and resistance levels for Niagen Bioscience Inc.Market Movers & AI Optimized Trading Strategy Guides - Newser
How to track smart money flows in Niagen Bioscience Inc.July 2025 Pullbacks & Capital Efficient Trade Techniques - Newser
Niagen Bioscience: A Great Company Suffering From Stock Dilution - Seeking Alpha
Reversal indicators forming on Niagen Bioscience Inc. stockWeekly Trend Recap & Expert Curated Trade Setup Alerts - Newser
How to use Fibonacci retracement on Niagen Bioscience Inc.Wall Street Watch & Accurate Entry/Exit Alerts - Newser
Published on: 2025-09-08 00:24:58 - Newser
Niagen Bioscience, Inc. (NASDAQ:NAGE) Given Consensus Rating of "Buy" by Analysts - MarketBeat
Can Niagen Bioscience Inc. stock double in the next yearQuarterly Market Review & AI Powered Buy and Sell Recommendations - خودرو بانک
Niagen Bioscience (NASDAQ:NAGE) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Niagen Bioscience Inc Stock (NAGE) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):